Supplements in the News
|Omega-3 Supports Major Depressive Disorder|
|Published Saturday, May 3, 2008 4:00 am|
TEHRAN, Iran—A recent trial study at Tehran University of Medical Sciences compared eicosapentaenoic acid (EPA) and fluoxetine (Prozac), separately and combined, in major depressive disorder (Aus N Eng J Psych. 2008;42(3):192-98). Sixty outpatients, diagnosed with major depressive disorder, were randomly assigned either 1000 mg/d of EPA, 20 mg/d of fluoxetine or a combination for eight weeks. The combination of EPA and fluoxetine was significantly better than fluoxetine or EPA alone from the fourth week of treatment. Fluoxetine and EPA appeared to be equally effective in controlling depressive symptoms. The response rates were 50 percent, 56 percent and 81 percent in the fluoxetine, EPA and combination groups, respectively.
This abstract provided courtesy of Natural Products Industry Insider, published by Virgo Publishing Inc.
Send this page to a friend |  Show Other Stories